# Dexmedetomidine-Ropivacine Versus Sufentanil-Ropivacaine for Epidural Labor Analgesia

> **NCT05698407** · PHASE4 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 200 (actual)

## Conditions studied

- Pregnancy Related

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Sufentanil

## Key facts

- **NCT ID:** NCT05698407
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-16
- **Primary completion:** 2023-06-15
- **Final completion:** 2023-08-28
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05698407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05698407, "Dexmedetomidine-Ropivacine Versus Sufentanil-Ropivacaine for Epidural Labor Analgesia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05698407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*